Medibyt
AI Platform for Cardiopulmonary Exercise Test Interpretation
Company Overview
Snapshot
Founded in May 2024 by Or Inbar and Niv Caspi, Medibyt operates with 1–10 employees. The company has raised $350,000 across two funding rounds, focusing on advancing its AI-powered cardiopulmonary exercise testing platform. In May 2024, Medibyt secured Pre-Seed funding to further develop its CPETWise product.
Business overview
Medibyt develops an AI-powered platform for cardiopulmonary exercise testing (CPET) designed to automate interpretation and streamline clinical workflows. Its core product, CPETWise, converts complex physiological data into structured, clinician-ready reports rapidly, significantly reducing analysis time. The cloud-based solution is compatible with existing metabolic systems, supports remote diagnostics, and integrates into hospital and outpatient settings, serving the healthcare industry within the Health Tech & Life Sciences sector.
Strategic signal
Medibyt's focus on AI-driven CPET interpretation, as highlighted by a March 2025 article in the European Journal of Applied Physiology, signals a paradigm shift towards more comprehensive medical evaluation of exercise function. This indicates a growing industry recognition of AI's potential to enhance diagnostic accuracy and accessibility in cardiopulmonary care, positioning Medibyt at the forefront of this technological advancement.
Log in to access full profile ›Company Intelligence Q&A
- What is Medibyt's primary product?
- Medibyt's primary product is CPETWise, an AI-powered platform that automates the interpretation of cardiopulmonary exercise tests (CPET) and generates structured, clinician-ready reports.
- When was Medibyt founded and by whom?
- Medibyt was founded in May 2024 by Or Inbar and Niv Caspi.
- What is the total capital raised by Medibyt?
- Medibyt has raised a total of $350,000 across two funding rounds.
- What is the core technology behind Medibyt's platform?
- Medibyt's platform leverages artificial intelligence, specifically machine learning, to interpret cardiopulmonary exercise test data.
- What market does Medibyt primarily serve?
- Medibyt primarily serves the healthcare market, focusing on providers within the Health Tech & Life Sciences sector, with its solutions for medical decision support.